Elevian

Elevian is in the business of creating rejuvenating drugs that focus on fundamental aging processes. It is a venture originating from Harvard, managed by a group of experienced business owners and Harvard researchers. The creators of Elevian have pinpointed blood elements that manage aging and activate the body's inherent restoration and renewal mechanisms. A notable instance is GDF11, which diminishes age-related heart enlargement, speeds up the mending of skeletal muscles, and enhances mental capabilities in older animals. We are formulating biological therapeutics that control these blood elements. Through addressing core aging mechanisms, Elevian's treatments have the potential to provide remedies for age-related conditions.